Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 1, 2008, Pages 1-8

  Hudnall, S David ^a   Betancourt, Eve ^a   Barnhart, Erin ^a   Patel, Jyoti ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Flow cytometry; Hodgkin lymphoma; Hodgkin's disease; Reactive lymphoid hyperplasia

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; FLUOROCHROME; MONOCLONAL ANTIBODY;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; LYMPHOCYTE SUBPOPULATION; LYMPHOID HYPERPLASIA; NATURAL KILLER T CELL; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PRIORITY JOURNAL;

CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE SUBSETS; PSEUDOLYMPHOMA; RETROSPECTIVE STUDIES;

EID: 38349059247     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20376     Document Type: Article

References (14)

1. van den Berg A, Visser L. Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999;154:1685-1691.
2. Ohshima K, Tutiya T, Yamaguchi T, Suzuki K, Suzumiya J, Kawasaki C, Haraoka S, Kikuchi M. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells. Int J Cancer 2002;98:567-572.
3. Xu Y, Kroft SH, McKenna RW, Aquino DB. Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: A multiparameter flow cytometry study. Br J Haematol 2001;112:945-949.
4. Martin J, Warnke R. A quantitative comparison of T cell subsets in Hodgkin's disease and reactive hyperplasia. Cancer 1984;53:2450-2455.
5. Ravoet C, Demartin S, Gerard R, Dehon M, Peny MO, Petit B, Delannoy A, Husson B. Contribution of flow cytometry to the diagnosis of malignant and non malignant conditions in lymph node biopsies. Leuk Lymphoma 2004;45:1587-1593.
6. Pituch-Noworolska A, Drabik G, Kacinska E, Klekawka T. Lymphocyte populations in lymph nodes in different histological types of Hodgkin's disease in children. Acta Haematol 2004;112:129-135.
7. Kandil A, Bazarbashi S, Mourad WA. The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease. Cancer 2001;91:1957-1963.
8. Frisan T, Sjoberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A, Brautbar C, Battat S, Biberfeld P, Eckman M, Ost A, Christensson B, Sundstrom C, Bjorkholm M, Pisa P, Masucci MG. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995;86:1493-1501.
9. Poppema S, van den Berg A. Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas. Semin Cancer Biol 2000;10:345-350.
10. Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN, Vickers MA. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004;103:1755-1762.
11. Alvaro T, Lejeune M, Salvado MT, Bosch R, Garcia JF, Jaen J, Banham AH, Roncador G, Montalban C, Piris MA. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467-1473.
12. Ishida T, Ishii T, Inagaki A, Yano H, Komatsu H, Iida S, Inagaki H, Ueda R. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006;66:5716-5722.
13. ten Berge RL, Oudejans JJ, Dukers DF, Meijer JW, Ossenkoppele GJ, Meijer CJ. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: An independent biological prognostic marker. Leukemia 2001;15:458-464.
14. Bosch Princep R, Lejeune M, Salvado Usach MT, Jaen Martinez J, Pons Ferre LE, Alvaro Naranjo T. Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma. Ann Hematol 2005;84:661-666.